Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists
The therapeutic use of A<sub>2A</sub> adenosine receptor (AR) antagonists for the treatment of neurodegenerative disorders, such as Parkinson and Alzheimer diseases, is a very promising approach. Moreover, the potential therapeutic role of A<sub>2A</sub> AR antagonists to avo...
Saved in:
Main Authors: | Flavia Varano (Author), Daniela Catarzi (Author), Erica Vigiani (Author), Fabrizio Vincenzi (Author), Silvia Pasquini (Author), Katia Varani (Author), Vittoria Colotta (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A<sub>1</sub> and A<sub>2A</sub> Receptors, and Efficacy in Animal Models of Depression
by: Flavia Varano, et al.
Published: (2021) -
Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors. Ranging from Pan Ligands to Combined A1/A2B Partial Agonists
by: Daniela Catarzi, et al.
Published: (2019) -
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles
by: Lucia Squarcialupi, et al.
Published: (2017) -
Special Issue "Adenosine Receptors as Attractive Targets in Human Diseases"
by: Daniela Catarzi, et al.
Published: (2021) -
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives
by: Daniela Catarzi, et al.
Published: (2022)